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Abstract
Background: We sought to noninvasively investigate skin microcirculation and to assess the
relation between parameters of microcirculation and echocardiographic and biochemical pa-
rameters of left ventricular (LV) function in non-diabetic patients with heart failure (HF).
Methods and Results: We measured skin microcirculation with laser Doppler flowmetry
(LDF) at basal conditions (MFb), after warming to 44 degrees Centigrade (MF44) and after
occlusion (AUC, PF%). Blood was sampled for NT-proBNP. We obtained information on
patients’ medical history and medication status. The mean (SD) age of 100 patients (43 women)
was 68.2 ± 11.5 years. LV ejection fraction (LVEF) averaged 34.9 ± 13.3%, LV end-diastolic
diameter (LVEDD) 6.0 ± 0.9 cm, NT-proBNP 4,582.6 ± 6,339.7 pg/mL. The parameters of
microcirculation averaged: MFb 6.2 ± 4.7 perfusion units (PU), PF% 716.0 ± 437.8%, AUC
794 ± 706.1 PU/s, and MF44 77.9 ± 40.2 PU. NT-proBNP correlated negatively with LVEF
(p £ 0.0001) and positively with LVEDD (p = 0.003). MFb was positively correlated with
LVEF (r = 0.24, p = 0.03), and MF44 was negatively correlated with LVEDD (r = 0.22,
p = 0.02). The relations remained significant after adjustments for sex, age, and use of
medication. We observed no relation between NT-proBNP and microcirculatory derangement.
Conclusions: LDF-derived parameters of skin microcirculation are related to echocardiogra-
phic, but not biochemical, indices of HF. (Cardiol J 2011; 18, 3: 270–276)
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Introduction
Microcirculation is one of the major players in
the pathophysiology of heart failure (HF). Data from
small-scale studies (mainly employing video-capil-
laroscopy) has shown a relation between degree of
derangement in microcirculatory function and indi-
ces of left ventricular performance. However, many
of these studies included diabetic patients, a fact
which could have influenced the results.
Heart failure involves alterations in the struc-
ture and function of the cutaneous, skeletomuscular
and coronary microcirculatory vessels. Dysfunction
of peripheral circulation is a common feature of he-
modynamic derangement in patients with HF. He-
modynamic changes in microcirculatory blood flow
influence the redistribution of the output of a failing
heart. An impaired vasomotor reaction of microcircu-
latory vessels occurs as a result of inflammation, dys-
function and apoptosis of endothelial cells [1].
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Moreover, not only vasomotor, which is endo-
thelium dependent, but also endothelium-indepen-
dent, reactions are impaired in HF. Abnormal pe-
ripheral blood flow causes progressive ischemia and
malnutrition of tissues and organs, which may be
involved with the progression of the disease.
The aim of our study was to assess skin mi-
crocirculation using laser Doppler flowmetry (LDF),
and to establish whether a relation exists between
microcirculatory parameters and important indices
describing left ventricular (LV) function, levels of
N-terminal pro-brain natriuretic peptide (NT-proBNP)
and the prescribed medication in patients treated
for HF.
In a relatively large group (and one which ex-
cluded patients with diabetes mellitus), we show that
impairment in skin microcirculation parallels impair-
ment in left ventricular function, but is not cross-
sectionally related to the level of NT-proBNP.
Methods
We diagnosed HF based on the criteria set out
by the European Society of Cardiology [2]. Each
patient was interviewed to obtain information on the
symptoms and signs of HF. We graded the severi-
ty of HF using the New York Heart Association
(NYHA) classification. We also obtained information
regarding the cause of hospitalization, any co-mor-
bidity (coronary artery disease — CAD, myocardial
infarction — MI, hypertension, hypercholeste-
rolemia), smoking status, alcohol intake, family his-
tory of cardiovascular disease, and medication use.
In the framework of physical examination we col-
lected anthropometric data. Sitting conventional
blood pressure (BP) was measured twice in stan-
dard conditions, in accordance with current recom-
mendations [3]. A standard transthoracic echocar-
diogram was performed using GE Vivid 4. We sam-
pled blood to assess NT-proBNP levels. Forearm
skin microcirculatory blood flow was measured in
all subjects using LDF (Perimed, Sweden). LDF is
based on the Doppler phenomenon, using light with
a wavelength of 780 nm. Measurements of the cu-
taneous microcirculation were obtained with the
probe fixed at the forearm, with the patient in the
supine position. Microcirculatory measurements
included three-minute determination of flow under
basal conditions, followed by three-minute forearm
ischemia elicited by arm occlusion using a conventio-
nal sphygmomanometer cuff at a pressure 50 mm Hg
higher than the patient’s systolic BP (SBP) at the
beginning of the assessment. Next, cutaneous blood
flow was measured during a three-minute post-
-occlusive procedure (hyperemic reaction). The
probe temperature was then increased to 44 de-
grees Centigrade, and the flow was measured for
eight minutes. The following indices were obtained:
mean blood flux under basal conditions (MFb) ex-
pressed in perfusion units (PU); area under the
curve (AUC) of flow recorded after three-minute
arm occlusion during hyperemic reaction; peak flow
during hyperemic reaction measured as a percent-
age increase in comparison to basal flow (PF%), and
mean cutaneous blood flow at the temperature of
44 degrees Centigrade (MF44). All indices were
measured considering the biological zero, which is
a signal received during forearm ischemia.
Microcirculatory flow was measured in the
hospitalized patients after stabilization of their clini-
cal status i.e. when they were free of symptoms of
decompensation (dyspnea, tachycardia, peripheral
edema) on the day of the microcirculatory assess-
ment. Any patients who required intravenous diu-
retics or intravenous inotropic agents, or who had
fever, disseminated cancer or diabetes mellitus,
were excluded from the study.
The study was approved by the local bioethi-
cal committee and all patients gave their informed
consent.
Statistical analysis
The database management and the statistical
analysis were performed using SAS 9.2 version and
JMP 5.1 Academic Edition. Means were compared
using Student’s t-test and the analysis of variance
(ANOVA), the proportions using the c2 test. When-
ever the distribution of the variables departed sig-
nificantly from the normal distribution, logarithmic
transformation was used. In cases where, even af-
ter the transformation, distributions were not nor-
mal, the nonparametric Wilcoxon test was used to
compare two groups, and the Kruskal-Wallis test
for comparisons across more than two groups. The
relation between parameters of skin microcircula-
tion and factors putatively influencing them was
assessed first using correlation analysis, and sub-
sequently using regression with stepwise selection
of explanatory variables.
Results
The average age ± SD of the 100 patients in-
cluded in the study was 68.2 ± 11.5 years, and 57%
of them were male. Systolic and diastolic BP aver-
aged 135.1 ± 21.9 and 80.0 ± 10.9 mm Hg, respec-
tively. Women were significantly older (72.4 ± 10.5
vs 65.0 ± 11.3, p < 0.01, respectively), had lower
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body weight (65.9 ± 13.2 vs 78.7 ± 14.4, p < 0.001,
respectively), were shorter (157.9 ± 5.9 vs 171.5 ±
± 7.3, p < 0.001, respectively) and had a lower
waist to hip ratio (0.89 ± 0.09 vs 0.99 ± 0.07,
p < 0.001, respectively). Men had lower SBP
(141.2 ± 24.0 vs 130.5 ± 19.1, p < 0.05, respec-
tively) and heart rate (82.0 ± 15.7 vs 75.0 ± 14.9,
p < 0.01, respectively). Forty one per cent of patients
were hospitalized for exacerbations of chronic HF,
21% were hospitalized for MI, and 12% for pulmo-
nary edema. Patients in NYHA class II accounted for
34% of the group, while those in the third and fourth
classes represented 61% and 5%, respectively.
Twenty eight per cent of patients had HF and atrial
fibrillation, 87% CAD, 68% history of MI, and 88%
hypertension. Eighty eight per cent of the analyzed
group had LV systolic dysfunction, whereas 12% had
HF with preserved systolic function. Most patients
(87%) were treated with angiotensin-converting
enzyme inhibitors (ACEI). Beta-blockers were
administered to 75% of patients, diuretics to 81%,
and acetylsalicylic acid (ASA) to 76% patients. Of the
75 patients who were receiving beta-blockers, 24 re-
ceived carvedilol. The laboratory and echocardiogra-
phic parameters are set out in Table 1.
Microcirculatory parameters averaged as fol-
lows: MFb 6.2 ± 4.7 PU, PF% 716.0 ± 437.8, AUC
794.0 ± 706.2 PU/s, MF44 77.9 ± 40.2 PU. Apart
from MF44, there were no sex-related differences
in measures of skin microcirculation (Table 2).
When compared to patients with LV ejection frac-
tion  (LVEF) < 45%, 12 patients with preserved
systolic function had higher MFb, and MF44 (all
p < 0.01), but did not differ with respect to levels
of PF% and AUC (Table 3). Sixty seven patients
with LV end-diastolic diameter (LVEDD) ≥ 5.6 cm,
when compared to patients without LV dilation
had lower AUC (p < 0.01) and MF44 (p < 0.001)
(Table 4).
The median (range) concentration of
NT-proBNP was 2,727.0 (125 – > 35,000) pg/mL.
No relation was found between the parameters of
microcirculatory blood flow and concentration of
NT-proBNP.
Table 1. Group characteristics — laboratory and echocardiography parameters.
Laboratory parameters Women Men
Erythrocytes [106/mL] 4.63 ± 5.11 4.57 ± 5.62
Glucose [mmol/L] 5.20 ± 0.64 5.20 ± 0.75
Creatinin [mmol/L] 84.14 ± 24.42 99.89 ± 28.64**
Total cholesterol [mmol/L] 5.19 ± 0.97 4.63 ± 1.05**
NT-proBNP [pg/mL] 4079.92 ± 5846.41 4952.97 ± 6706.79
Left atrium [cm] 4.93 ± 0.83 5.01 ± 0.67
LVEDD [cm] 5.49 ± 0.91 6.39 ± 1.02***
LVEF (%) 40.25 ± 16.32 30.91 ± 11.11***
E/A 1.08 ± 0.70 1.11 ± 0.80
Vp [cm/s] 49.98 ± 22.51 43.73 ± 21.03
Level of significance: ***p < 0.001, **p < 0.01, *p < 0.05; LVEDD — left ventricular end-diastolic diameter; LVEF — left ventricular ejection fraction
Table 2. Group characteristics — microcirculatory parameters.
Women Men
Mean ± SD Median Mean ± SD Median
MFb 6.3 ± 4.9 4.78 6.2 ± 4.6 4.83
PF% 781.2 ± 552.3 654.2 666.8 ± 323.2 636.8
AUC 959.9 ± 920.5 611.6 669.5 ± 457.6 593.4
MF44 90.3 ± 47.3 58.7 68.31 ± 3** 75.6
Level of significance ***p < 0.001, **p < 0.01, *p < 0.05; MFb — mean flow in basal conditions; PF% — peak flow in hyperemic reaction;
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The relation between microcirculatory parame-
ters and echocardiographic indices was analyzed
using the linear regression approach. A significant
positive relation was found between the mean flow
in basal condition and LVEF, and a significant ne-
gative relation was found between the mean flow
in the temperature of 44 degrees Centigrade and
LV diastolic diameter (Figs. 1, 2). This was further
confirmed in the multivariate analyses where we ad-
justed for sex, age, use of beta-blockers, ACEI, st-
atins, ASA and nitrates.
Intake of drugs and parameters
of skin microcirculation
In the above models, both in men and women
separately and in the entire group, after adjustment
for other confounders (including EF or LVEDD),
intake of ACEI was positively associated with MF44
(all p < 0.008), and the use of beta-blockers was
positively associated with MFb (all p < 0.002).
In the sensitivity analysis, we repeated our mod-
els excluding patients receiving carvedilol. In these
models, the use of beta-blockers other than carvedilol
was negatively related with MFb (all p < 0.03).
Discussion
We demonstrated a relation between impaired
skin microcirculation as assessed with LDF and
Table 3. Differences in microvascular parameters between patients with and without preserved
left ventricle (LV) systolic function.
Parameter Preserved LV systolic function LV systolic dysfunction
n = 12 (EF > 45%) n = 88 (EF £ 45%)
Mean ± SD Median Mean ± SD Median
MFb 8.7 ± 3.6 8.0 5.9 ± 4.8** 4.5
PF% 631.9 ± 433.9 533.3 727.5 ± 439.6 672.9
AUC 635.6 ± 331.9 644.9 815.5 ± 741.3 610.9
MF44 99.6 ± 36.0 85.4 74.9 ± 40.0** 64.8
Levels of significance: ***p < 0.001, **p < 0.01, *p < 0.05; abbreviations as in Table 2
Table 4. Differences in microvascular parameters between patients with and without left ventricular
enlargement.
Parameter LVEDD < 5.6 cm (n = 32) LVEDD ≥ 5.6 cm (n = 67)
Mean ± SD Median Mean ± SD Median
MFb 7.0 ± 5.4 4.9 5.9 ± 4.4 4.4
PF% 753.8 ± 384.0 680.9 700.8 ± 465.6 652.5
AUC 1032.5 ± 867.8 790.7 684.1 ± 594.4** 481.8
MF44 98.6 ± 40.0 88.3 67.8 ± 36.8*** 56.9
Levels of significance: ***p < 0.001, **p < 0.01, *p < 0.05; abbreviations as in Tables 1 and 2
Figure 1. Relation between mean flow in basal condi-
tions (MFb) and left ventricular ejection fraction (LVEF)
(r = 0.24, p = 0.03).
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echocardiographic indices of HF. However, we
were unable to demonstrate such a relation for bio-
chemical (NT-proBNP) markers of circulatory de-
compensation. In our analyses, we showed that in-
take of ACEI (when adjusted for indices of LV struc-
ture and systolic function) is associated with higher
microcirculatory flow at 44 degrees Centigrade, and
that in corresponding analyses the use of beta-
-blockers is associated with higher microcirculatory
flow under basal conditions, when patients receiv-
ing carvedilol are included. The analysis of indices
of microcirculatory function in patients with conges-
tive HF demonstrated that LV enlargement, which
characterizes the remodeled heart and the process
of left ventricle adaptation, was directly related to
microcirculatory functional impairment, both under
basal conditions and at increased temperature. Also,
reduction of EF was accompanied by microcircula-
tory flow deterioration. Thus, we found that micro-
circulatory blood flow under basal conditions was
lower in hospitalized patients with EF < 45%. This
was confirmed by a decrease of flow at 44 degrees
Centigrade. In a group with LV dilatation, flow at
44 degrees Centigrade was lower, and furthermore
we found that the area under the curve of hypere-
mic reaction was significantly smaller in individu-
als with LVEDD > 5.6 cm. This was largely con-
firmed after adjusting for sex, age and medications.
A number of studies have investigated the re-
lation between skin microcirculation and LV per-
formance. Duprez et al. [4], using computer-assist-
ed videocapilaroscopy, showed that, in patients with
HF, cutaneous microcirculation correlated with
echocardiographic indices in a similar manner to our
findings. Duprez et al. [4] found that the capillary
blood flow velocity was positively correlated with
LVEF and negatively correlated with LV end-sys-
tolic and end-diastolic diameter.
Houben et al. [5] showed that patients with
severe HF had a lower density of microcirculatory
vessels, reduced vasodilatatory reserve and abnor-
malities in microcirculatory morphology. In the
group with HF mostly due to CAD, the percentage
of abnormal conjunctival arterioles was negatively
related with LVEF. A similar relation was noted
when the authors considered abnormal morpholo-
gy of capillaries [5]. The ability of microcirculatory
vessels to relax is impaired in patients with HF due
to dilated cardiomyopathy, as compared to healthy
controls [6]. No relationship was detected between
vasodilatation of microcirculation or stage of mi-
croangiopathy and either LVEF, NYHA class, or the
duration of HF. However, that study included a re-
latively small group of patients [6].
Dilated cardiomyopathy can serve as a model
for HF devoid of atherosclerotic background. Still,
some reports show similar impairment of microcir-
culation in patients with cardiomyopathy and CAD
and in patients with dilatative cardiomyopathy [7].
In our study, impairment of basal flow was asso-
ciated with LV diastolic dysfunction. To the best of
our knowledge, there have been no analyses of mi-
crocirculatory blood flow and its relation to left ven-
tricle diastolic function in patients with HF.
We found no relation between levels of NT-
-proBNP and parameters of microcirculatory blood
flow. Many factors could influence the levels of
natriuretic peptide in the analyzed population, for
instance advanced age, renal insufficiency, gender,
atrial fibrillation, hypertension, acute coronary syn-
drome as a reason for admission to hospital, and
ongoing, often intensive, treatment for HF. More-
over, NT-proBNP is produced by cardiomiocytes
which represent only one third of the myocardium,
while there are many more cells involved in the pro-
cess of progression of HF. These are cells of the
immune system and inflammation that are impor-
tant in the regulation of peripheral blood flow, hy-
poxia and malnutrition of tissues and organs [8].
Therefore, markers of endothelial dysfunction,
cytokines, products of monocyte and macrophage
activation, or heat shock proteins probably could
have been better markers of microcirculatory flow
regulation than natriuretic peptides. One study
showed no relation between the markers of endo-
Figure 2. Relation between flow in 44 degrees Centigrade
(MF44) and left ventricular end-diastolic diameter (LVEDD)
(r = 0.22, p = 0.02).
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thelial activation and BNP levels in patients with
HF [9]. Andersson et al. [10] studied microcircula-
tory reaction to vasodilatatory factors, both
endothelium-dependent and independent, and heat.
The authors performed microcirculatory assess-
ment using LDF, and found no relation between
BNP levels and the vasodilatatory capacity of skin
microcirculatory vessels.
Pharmacological treatment including drugs
acting on the renin-angiotensin-aldosterone sys-
tem, statins, ASA and beta-blockers may influence
microcirculation via both endothelium dependent
and independent mechanisms [11]. Therefore, we
adjusted our analyses for the possible effect of
drugs. Likewise, we assessed the microcirculatory
function exclusively in stable patients, who did not
require intravenous furosemide.
The group of patients we investigated differed
from other analyses with respect to important chara-
cteristics. When compared to other studies, our
patients were younger, but at the same time their
overall condition was poorer. They had more ad-
vanced HF, more advanced CAD, and more often
presented with a history of MI and hypertension.
Another substantial difference was that by defini-
tion we excluded diabetic patients in whom we
would expect overlap of diabetes-related factors
interfering with microcirculation. This may have
resulted in under-representation in our group of
patients with renal insufficiency or other common
complications of diabetes mellitus.
Our study needs to be considered in the con-
text of its limitations. Our sample was relatively
small. We also selectively excluded patients with
diabetes mellitus. However, the exclusion of dia-
betic subjects resulted in a higher homogeneity of
microcirculatory derangement in our patients. In
our study, we assessed skin microcirculation using
LDF. The major advantage of LDF rests with its
noninvasiveness and that it permits assessment of
the dynamic reactivity of the microcirculation in
response to thermal and metabolic stimuli of vasodi-
latation (heat and hyperemia) [12].
The question is: why do patients with impaired
LVEF and dilated left ventricle have impaired mi-
crocirculation? Perhaps the answer is that it reflects
the endothelial dysfunction in patients with HF that
promotes microcirculatory deterioration. Indeed,
LDF is considered a method of assessment of en-
dothelial function of skin microcirculatory vessels
[13]. Several studies have shown an improvement
in endothelial function and microcirculation after
heart transplantation [14, 15] or with pharmacolo-
gical treatment [16–18], mainly with ACEI [19] or
statins [20, 21].
Conclusions
In the context of the presented data, and the
reports described above, it seems that microcircu-
latory function assessed with LDF could be used
as a prognostic factor in patients with HF, possibly
irrespective of its cause. This hypothesis could be
proven in carefully designed, prospective studies
of large and homogenous groups of patients.
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